Evidence map›Paper›PMID 26926912›Full record

ReviewMutation research2016

FANCJ at the FORK.

Sharon B Cantor, Sumeet Nayak

Abstract readReview
In one paragraph

Review in Mutation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. The Genetic and Molecular Analyses of Rare Candidate GermlineInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. The repair geneOncology reviews · 2021
    Article
  7. Review
  8. SOG1 activator and MYB3R repressors regulate a complex DNA damage network inProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  9. Article
  10. Fork Protection and Therapy Resistance in Hereditary Breast Cancer.Cold Spring Harbor symposia on quantitative biology · 2017
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sharon B CantorDepartment of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, UMASS Memorial Cancer Center, Worcester, Massachusetts 01605, USA. Electronic address: sharon.cantor@umassmed.edu.
Sumeet NayakDepartment of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, UMASS Memorial Cancer Center, Worcester, Massachusetts 01605, USA.

Funding

Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian CancerR01CA176166 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CANTOR, SHARON B · 2014 to 2018
$1.7M
Single-molecule studies of BRCA1-BACH1 mechanism in genomic integrityR21CA187612 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2015 to 2016
$451k
NCI NIH HHS R01 CA176166NCI NIH HHS R21 CA187612
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA ReplicationAnimalsBasic-Leucine Zipper Transcription FactorsBRCA1 ProteinDNA RepairFanconi Anemia Complementation Group ProteinsHumansMutS Homolog 2 ProteinBACH1 protein, humanBasic-Leucine Zipper Transcription FactorsBRCA1 ProteinFanconi Anemia Complementation Group ProteinsMSH2 protein, humanMutS Homolog 2 Protein

Identifiers

PMID26926912
PMCPMC4887407

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.